Contineum Therapeutics (CTNM) Capital Expenditures (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Capital Expenditures of $6000.0 for Q2 2026, down 86.36% year-over-year from $44000.0 in Q2 2025, and down 98.08% quarter-over-quarter from $312000.0 in Q1 2026.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Capital Expenditures (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Capital Expenditures history runs 4 years deep, the most recent figure standing at $6000.0 for Q2 2026.
- In Q2 2026, Capital Expenditures fell 86.36% year-over-year to $6000.0; the TTM figure through Jun 2026 stood at $458000.0 (up 408.89% YoY), while the FY2025 annual figure was $231000.0, up 124.65% from the prior year.
- Capital Expenditures for Q2 2026 stood at $6000.0, down from $312000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $312000.0 in Q1 2026, with the low at -$1.1 million in Q2 2024.
- The 4-year median for Capital Expenditures is $44000.0 (2025), against an average of $2000.0.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures sank 3593.55% in 2024, then surged 9900.0% in 2025.
- Contineum Therapeutics' Capital Expenditures stood at $309000.0 in 2023, then slumped by 100.32% to -$1000.0 in 2024, then soared by 4300.0% to $42000.0 in 2025, then sank by 85.71% to $6000.0 in 2026.
- Business Quant data shows CTNM's Capital Expenditures at $6000.0 in Q2 2026, $312000.0 in Q1 2026, and $42000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Contineum Therapeutics | 628.71 Mn | 628.71 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1.08 Mn |
| Mar 31, 2024 | 147,000.00 |
| Dec 31, 2023 | 309,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | 52,000.00 |